The Community Guide

- gsearch

Search Results

Narrow Results:

2022 1
2021 1

Germany 1

Journal Article 2

Letter 1

1 - 2 of 2 Results

Refine Results

Refine Results:

Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February–March 2021

CITE Title : Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February–March 2021 Personal Author(s) : Tober-Lau, Pinkus;Schwarz, Tatjana;Hillus, David;Spieckermann, Jana;Helbig, Elisa T.;Lippert, Lena J.;Thibeault, Charlotte;Koch, Willi;Bergfeld, Leon;Niemeyer, Daniela;Mühlemann, Barbara;Conrad, Claudia;Kasper, Stefanie;Münn, Friederike;Kunitz, Frank;Jones, Terry C.;Suttorp, Norbert;Drosten, Christian;Sander, Leif Erik;Kurth, Florian;Corman, Victor M.; Published Date : August 2021 Source : Emerg Infect Dis. 27(8):2169-2173 URL : https://stacks.cdc.gov/view/cdc/108809 Tober-Lau, Pinkus et al. (2021). Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February–March 2021. 27(8). Tober-Lau, Pinkus et al. "Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February–March 2021" 27, no. 8 (2021) Tober-Lau, Pinkus et al. "Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February–March 2021" vol. 27, no. 8, 2021 Export RIS Citation Information.

:

Tober-Lau, Pinkus ;

Schwarz, Tatjana

August 2021 | Emerg Infect Dis. 27(8):2169-2173

:

One week after second vaccinations were administered, an outbreak of B.1.1.7 lineage severe acute respiratory syndrome coronavirus 2 infections occurr...
Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections

CITE Title : Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections Personal Author(s) : Tober-Lau, Pinkus;Gruell, Henning;Vanshylla, Kanika;Koch, Willi M.;Hillus, David;Schommers, Philipp;Suárez, Isabelle;Suttorp, Norbert;Sander, Leif Erik;Klein, Florian;Kurth, Florian; Published Date : 5 2022 Source : Emerg Infect Dis. 2022; 28(5):1050-1052 URL : https://stacks.cdc.gov/view/cdc/117307 Tober-Lau, Pinkus et al. (2022). Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections. 28(5). Tober-Lau, Pinkus et al. "Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections" 28, no. 5 (2022) Tober-Lau, Pinkus et al. "Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections" vol. 28, no. 5, 2022 Export RIS Citation Information.

:

Tober-Lau, Pinkus ;

Gruell, Henning

5 2022 | Emerg Infect Dis. 2022; 28(5):1050-1052

:

To determine neutralizing activity against the severe acute respiratory syndrome coronavirus 2 ancestral strain and 4 variants of concern, we tested s...